Search Results - anahid+jewett

8 Results Sort By:
Cannabis Limits Cancer Stem Cell Growth in Poorly Differentiated Cancers (UCLA Case No. 2020-869)
Contact UCLA Technology Development Group for more information.
Published: 10/23/2025   |   Inventor(s): Anahid Jewett
Keywords(s):  
Category(s): Therapeutics > Oncology
Unique Tests to Assess the Expansion and Function of Natural Killer Cells in Health and Disease (UCLA Case No. 2019-635)
UCLA researchers in the School of Dentistry have developed a unique set of tests to determine the expansion and function of natural killer cells in healthy subjects and cancer patients. BACKGROUND: Natural killer (NK) cells have the remarkable ability to target cancer stem cells (CSCs) and undifferentiated tumors. However, downregulation of NK receptors...
Published: 10/23/2025   |   Inventor(s): Anahid Jewett
Keywords(s):  
Category(s): Diagnostic Markers > Immunology, Therapeutics > Immunology And Immunotherapy, Life Science Research Tools > Cell Lines
Sonicated Osteoclasts as Drugs to Increase NK Expansion and Function in Patients and in Manufacturing of NK Cells (Case No. 2024-272)
UCLA researchers from the Department of Dentistry have developed an innovative method to manufacture, expand and improve the function of natural killer cells by using sonicated osteoclasts for cancer immunotherapy. BACKGROUND: Natural killer cells (NK cells) are immune cells that recognize and combat pathogens and cancer cells. NK cell immunotherapy...
Published: 10/23/2025   |   Inventor(s): Anahid Jewett
Keywords(s):  
Category(s): Therapeutics > Oncology, Therapeutics > Immunology And Immunotherapy, Therapeutics > Oncology > Oncology Immunotherapy
Curative Locoregional Therapy Using Ablation or Catheter-Based Embolization of Targeted Hepatocellular Carcinoma by Delivering Supercharged NK Cells and CAR-NK or CAR-T Cells (UCLA Case No. 2023-115)
UCLA researchers in the School of Dentistry and Interventional Radiology have developed a groundbreaking curative treatment for hepatocellular carcinoma that combines locoregional therapy, such as ablation or catheter-based embolization, with targeted delivery of supercharged NK cells and CAR-NK or CAR-T cells, offering a highly effective approach that...
Published: 10/31/2025   |   Inventor(s): Anahid Jewett, Steven Raman, Jason Chiang
Keywords(s):  
Category(s): Therapeutics > Oncology, Therapeutics > Immunology And Immunotherapy, Therapeutics > Oncology > Oncology Immunotherapy
Synthetic Cannabinoid WIN 55,212-2 Increased the Cytotoxicity of NK Cells and IFN-gamma Secretion Ability of Immune Cells in Humanized BLT Mouse Model (UCLA Case No. 2022-281)
UCLA researchers in the School of Dentistry have developed novel strategies synergizing the anti-tumor effects of a synthetic cannabinoid, cytokine, and probiotic bacteria to augments NK cell mediated functions and target a wide variety of cancers and viral infections. BACKGROUND: Interest in the use of synthetic cannabinoids for the treatment of disease...
Published: 10/23/2025   |   Inventor(s): Anahid Jewett
Keywords(s):  
Category(s): Platforms > Drug Delivery, Therapeutics > Oncology > Oncology Immunotherapy
Combining Autologous or Allogeneic Total Monocytes or CD16+ Monocytes to Protect and Increase the Expansion and Function of Stem Cells (UCLA Case No. 2021-182)
SUMMARY: UCLA researchers in the department of Dentistry have developed a novel approach to increase the successful transplantation and survival of stem cells into patients. BACKGROUND: The World Health Organization has recognized that transplantation of human cells saves and restores essential life functions to patients who are not presented with...
Published: 10/23/2025   |   Inventor(s): Anahid Jewett
Keywords(s):  
Category(s): Therapeutics, Therapeutics > CNS and Neurology, Therapeutics > Immunology And Immunotherapy, Therapeutics > Stem Cells And Regenerative Medicine, Therapeutics > Stem Cells And Regenerative Medicine > Ips Stem Cells
Use of COX2 Knock Out Monocytes and Osteoclasts to Activate and Expand NK Cells (UCLA Case No. 2021-129)
SUMMARY: UCLA Researchers in the Department of Dentistry have developed a procedure to increase immune response in cancer patients. BACKGROUND: Natural killer (NK) cells are a type of cytotoxic lymphocyte critical to the innate immune system. NK cells provide rapid responses to viral infection and are also crucial to inhibiting tumor formation. They...
Published: 10/23/2025   |   Inventor(s): Anahid Jewett
Keywords(s):  
Category(s): Therapeutics, Therapeutics > Immunology And Immunotherapy, Therapeutics > Oncology, Therapeutics > Oncology > Oncology Immunotherapy
2006-585 DETOXIFIED AND OSTEOCONDUCTIVE BONE CEMENT
INTRO SENTENCE: UCLA researchers have developed a novel bone cement material for the treatment of osteoporotic fractures and degenerative joint disorders.BACKGROUND:Bone cement is a critical component of various types of orthopedic surgery that is used as spacers and for fixation of implants. Bone cement can be loaded with antibiotics to help with the...
Published: 7/17/2025   |   Inventor(s): Takahiro Ogawa, Anahid Jewett
Keywords(s): Medical Devices and Materials, Musculoskeletal Disease
Category(s): Therapeutics > Musculoskeletal Disease